Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2009-09-25

Supply shortage of Fabrazyme – updated treatment recommendations required for adult male patients

View source ↗

Summary

EMA updates treatment recommendations for Fabrazyme due to supply shortage, focusing on adult male patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FABRAZYME (Agalsidase beta)